RealPennies Featured Company: BioCurex, Inc. (BOCX.OB) RECAF Technology Could Revolutionize Cancer Testing
BioCurex, Inc. developed technology to specifically identify a cancer marker known as RECAF (TM), which is primarily found on malignant cells from a variety of cancer types, but is absent in most normal or benign cells. Currently, the company is in the process of developing and commercializing cancer diagnostic products based upon its breakthrough RECAF cancer marker technology. Their main products are Histo-RECAF, Cyro-RECAF and Serum-RECAF. The data that was produced by the company show that cancers in the breast, lung, stomach, and prostate consist of this molecule. This identifies that RECAF is present in a variety of tissue types.…